A randomized six-day safety study of an antiretroviral microbicide candidate UC781, a non-nucleoside reverse transcriptase inhibitor

Schwartz JL, Kovalevsky G, Lai J-J, Ballagh SA, McCormick T, Douville K, Mauck CK, Callahan MM
Sexually Transmitted Diseases 2008 35(4):414-419.